Macrocyclic Peptides (UCB SA/Merck & Co)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMacrocyclic Peptides (UCB SA/Merck & Co)
Drug Alias NameMacrocyclic Peptides (Ra Pharmaceuticals/Merck & Co)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co IncUcb Sa
Inactive CompaniesRa Pharmaceuticals Inc
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A